Premium
OBINUTUZUMAB CAN BE ADMINISTERED AS A 90‐MINUTE SHORT‐DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: GAZELLE END OF INDUCTION ANALYSIS
Author(s) -
Hübel K.,
Buchholz T. A.,
Izutsu K.,
Ishikawa T.,
Fogliatto L. M.,
Vorozheikina E.,
Klingbiel D.,
Pokala S.,
Tomiczek M.,
Parreira J.,
Canales M. A.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.30_2880
Subject(s) - medicine , obinutuzumab , follicular lymphoma , chemotherapy , chop , neutropenia , gastroenterology , surgery , rituximab , urology , lymphoma